Do adult disease severity subclassifications predict use of cyclophosphamide in children with ANCA-associated vasculitis? An analysis of ARChiVe study treatment decisions

Kimberly Morishita, Jaime Guzman, Peter Chira, Eyal Muscal, Andrew Zeft, Marisa Klein-Gitelman, America G. Uribe, Leslie Abramson, Susanne M. Benseler, Anne Eberhard, Kaleo Ede, Philip J. Hashkes, Aimee O. Hersh, Gloria Higgins, Lisa F. Imundo, Lawrence Jung, Susan Kim, Daniel J. Kingsbury, Erica F. Lawson, Tzielan LeeSuzanne C. Li, Daniel J. Lovell, Thomas Mason, Deborah McCurdy, Kathleen M. O'Neil, Marilynn Punaro, Suzanne E. Ramsey, Andreas Reiff, Margalit Rosenkranz, Kenneth N. Schikler, Rosie Scuccimarri, Nora G. Singer, Anne M. Stevens, Heather Van Mater, Dawn M. Wahezi, Andrew J. White, David A. Cabral

Pediatrics

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Sort by
Weight
Alphabetically

Do adult disease severity subclassifications predict use of cyclophosphamide in children with ANCA-associated vasculitis? An analysis of ARChiVe study treatment decisions

Fingerprint

Medicine & Life Sciences